Introduction

Nature of Business:

As a leader in the drive to advance rapid test technology, Artron BioResearch Inc. is a research-based company dedicated to developing, manufacturing and marketing novel protein-based rapid tests for detection of certain analytes in human and agriculture/food/crop samples. These tests, economical and easy to use in nature, will enable the rapid screening of large numbers of samples in markets previously constrained by high cost and slow turn-around time.
Artron develops recombinant proteins and monoclonal antibodies and critical components of one-step rapid test kits for research and diagnostic markets

Main Products

The company develops antibodies, recombinant antigens and critical components for the various rapid test kits for use by its corporate partners in connection with their manufacturing the commercial test kits.
(1) Recombinant Antigens and Monoclonal antibodies
(2) Key Components of RDT (Rapid diagnostic test) products (For the detection of Drugs of Abuse, Fertility (hCG, LH), Tumor markers, Infectious Diseases, etc)
Coated NC membrane
Colloidal Gold-protein conjugates

Main Customers and competitors

At present, our products won't be sold directly to the end-user consumer.
The primary customers are:
(1) Diagnostic Test Kit Manufacturers, looking for key biological components of the most updated products.
(2) Larger wholesalers, who have the brand name of the products and market-entry documents, but don't have manufacturing capacities for our advanced products.

Mission and Corporate Strategy:

At Artron BioResearch Inc, our mission is to meet and excel in the challenges of the biotech industry by bringing valuable testing technology that facilitates the detection of genetically modified products and medical diagnosis. We are committed to providing high quality products with competitive prices and excellent service to our customers.
Artron BioResearch Inc. R&D, manufactures, and markets high quality rapid diagnostic test kits in a variety of formats to meet the needs of the customer. This ability to provide quality products with a choice of formats, which are simple to use providing consistent product performance, translates into value for the customers.
Artron offers custom work utilizing advanced engineering techniques and a strong design team. Any of our current products can be customized to meet customer's needs
Artron is devoted to continuously upgrading the rapid diagnostic test products according to markets needs.
The Company expects that internal research and development project, primarily in the food safety area, will represent a larger percentage of its expenditures.
The company expects to expand from a primarily R&D Company to a well-rounded corporate entity. The company will be structured both scientifically and from a business perspective to meet challenges inherent in today's competitive biotechnology environment.

Technical capability

Artron operates in a 16000 sqf. facilitie, and is equipped with state of art R&D equipment for working in Molecular Biology, Monoclonal Antibody Development, Protein Purification and Rapid Test Kit Development. Artron currently has 3 Research Scientists, 2 Technology Specialist, and 10 Research Assistants.
The R&D teams of Artron pride themselves on responsiveness, innovation, andthe ability to scale up for large production.
Artron possesses the advanced technology required for the development and manufacture of novel RDT products.